Aquaviron 40 mg Softgel Capsule might increase the risk of prostate cancer. It is recommended to evaluate patients for prostate cancer before initiating and during treatment with Aquaviron 40 mg Softgel Capsule .

Aquaviron 40 mg Softgel Capsule may cause changes in anticoagulant activity. Therefore, frequent monitoring of prothrombin time and International Normalised Ratio (INR) is advised in patients taking anti-coagulants, especially during the initiation and termination of the treatment.

Aquaviron 40 mg Softgel Capsule may suppress sperm formation leading to fertility disorders. However, this effect may be reversible. Please consult your doctor if you have any concerns.

Testosterone has been subject to abuse resulting in dependence and withdrawal symptoms upon abrupt discontinuation or dose reduction. Therefore, take Aquaviron 40 mg Softgel Capsule only as advised by the doctor.

Aquaviron 40 mg Softgel Capsule may increase the red blood cell count in some patients, increasing the risk of a blood clot, heart attack, and stroke. Regular monitoring of red blood cell count and haemoglobin is advised.

Aquaviron 40 mg Softgel Capsule may cause venous thromboembolism (formation of a blood clot in the vein), including deep vein thrombosis (blood clot develops in a deep vein) and pulmonary embolism (blockage in the lung artery). Consult your doctor if you experience pain, oedema (swelling), warmth, erythema (skin redness) in lower proximity or shortness of breath.

No, Aquaviron 40 mg Softgel Capsule should not be used for building muscle mass and physical ability in healthy individuals, as it may cause harmful effects if used incorrectly.

It is usually recommended to take Aquaviron 40 mg Softgel Capsule with food or as advised by your doctor. The dose and duration will be decided by your doctor depending on your exact medical condition. Follow the doctor’s instructions. However, it is advised to take Aquaviron 40 mg Softgel Capsule at the same time every day, to maintain consistent levels of Aquaviron 40 mg Softgel Capsule in the body.

Aquaviron 40 mg Softgel Capsule may cause common side effects such as diarrhoea, increased red blood cells, heartburn, nausea, burping, enlarged prostate gland, headache and high blood pressure. If any of these side effects persist or worsen, please consult your doctor.

Aquaviron 40 mg Softgel Capsule is contraindicated in men with prostate cancer, breast cancer, and kidney disease. It should be avoided in patients with elevated calcium levels in blood and in patients who had or presently have liver cancer. Also, it is contraindicated in women, children below 18 years, and elderly patients over 65 years of age.

The major health risks associated with Aquaviron 40 mg Softgel Capsule therapy in men include stroke, heart attack, and prostate cancer.

When you are taking warfarin along with Aquaviron 40 mg Softgel Capsule , you should get blood tests done more often to check your bleeding time (time taken to stop bleeding) especially when starting and stopping Aquaviron 40 mg Softgel Capsule . Take your doctor’s advice.

Some effects of Aquaviron 40 mg Softgel Capsule may start showing after 3 weeks, while some may take longer. For example, effect on sexual interest appears after 3 weeks, while changes in erections/ejaculations may take up to 6 months.